Andreas Castan discusses the opportunities for efficiency gains in upstream manufacturing, including: the seed train, production bioreactor and perfusion.
Andreas Castan – Strategic Technology Partnerships Leader, Life Sciences, Cytiva
Andreas Castan provides leadership and support to the Bioprocess business. His main area of expertise is in upstream processing. Prior to joining Cytiva, Andreas was Director Upstream Development at Swedish Orphan Biovitrum, working with development of expression systems, process development of microbial and mammalian cell-based processes, and scale-up to cGMP manufacturing scales. During the last 20 years, Andreas has held several positions within biopharmaceutical development, including in project and line management, as well as manufacturing.